News & Updates
Filter by Specialty:
Antihypertensive drugs up risk of psoriasis
Use of antihypertensive medications is associated with the incidence of psoriasis, reports a study. Beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers (CCBs), and thiazide diuretics result in an increased risk of psoriasis.
Antihypertensive drugs up risk of psoriasis
17 Mar 2022Olaparib-abiraterone combo improves PFS in mCRPC
The combination of olaparib and abiraterone in the first-line setting improved radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC), results of the phase III PROpel trial showed.
Olaparib-abiraterone combo improves PFS in mCRPC
16 Mar 2022Roxadustat proven safe, effective for anaemia in CKD patients
Treatment with roxadustat leads to significant improvements in renal anaemia among patients with chronic kidney disease (CKD) by increasing haemoglobin (Hb) level and iron metabolism, according to a recent study. However, the risk of serious adverse events (AEs) during treatment must be considered.
Roxadustat proven safe, effective for anaemia in CKD patients
16 Mar 2022Corticosteroids help prevent hearing loss, neurologic sequelae in paediatric bacterial meningitis
Children with bacterial meningitis appear to fare well with corticosteroids, which lead to a lower incidence of hearing loss and neurologic sequelae and faster resolution of fever, according to a meta-analysis.
Corticosteroids help prevent hearing loss, neurologic sequelae in paediatric bacterial meningitis
15 Mar 2022Sofosbuvir easy on the kidneys
Use of sofosbuvir-based direct-acting antiviral regimens for treating hepatitis C virus (HCV) in clinical trial participants with chronic kidney disease (CKD) does not appear to worsen estimated glomerular filtration rate levels, according to a study. Furthermore, the drug does not appear to contribute to an increased risk of end-stage renal disease among HCV patients with CKD treated in clinical practice.